Authors:
APSELOFF G
FOULDS G
LABOYGORAL L
WILLAVIZE S
VINCENT J
Citation: G. Apseloff et al., COMPARISON OF AZITHROMYCIN AND CLARITHROMYCIN IN THEIR INTERACTIONS WITH RIFABUTIN IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 38(9), 1998, pp. 830-835
Authors:
STEVENS RC
REED MD
SHENEP JL
BAKER DK
FOULDS G
LUKE DR
BLUMER JL
RODMAN JH
Citation: Rc. Stevens et al., PHARMACOKINETICS OF AZITHROMYCIN AFTER SINGLE-DOSE AND MULTIPLE-DOSESIN CHILDREN, Pharmacotherapy, 17(5), 1997, pp. 874-880
Authors:
VINCENT J
FOULDS G
DOGOLO LC
WILLAVIZE SA
FRIEDMAN HL
Citation: J. Vincent et al., GRAPEFRUIT JUICE DOES NOT ALTER THE PHARMACOKINETICS OF AMLODIPINE INMAN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 70-70
Citation: Rl. Teng et al., DETERMINATION OF TROVAFLOXACIN, A NEW QUINOLONE ANTIBIOTIC, IN BIOLOGICAL SAMPLES BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 675(1), 1996, pp. 53-59
Authors:
FOULDS G
LUKE DR
TENG R
WILLAVIZE SA
FRIEDMAN H
CURATOLO WJ
Citation: G. Foulds et al., THE ABSENCE OF AN EFFECT OF FOOD ON THE BIOAVAILABILITY OF AZITHROMYCIN ADMINISTERED AS TABLETS, SACHET OR SUSPENSION, Journal of antimicrobial chemotherapy, 37, 1996, pp. 37-44
Citation: V. Meeyoo et al., THE KINETICS OF H2S DECOMPOSITION OVER PRECIPITATED COBALT SULFIDE CATALYST, Chemical engineering communications, 144, 1996, pp. 1-17
Authors:
TENG RL
GIRARD D
GOOTZ TD
FOULDS G
LISTON TE
Citation: Rl. Teng et al., PHARMACOKINETICS OF TROVAFLOXACIN (CP-99,219), A NEW QUINOLONE, IN RATS, DOGS, AND MONKEYS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 561-566
Citation: Dr. Luke et al., SAFETY, TOLERATION, AND PHARMACOKINETICS OF INTRAVENOUS AZITHROMYCIN, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2577-2581
Citation: Aa. Adesina et al., THERMOLYSIS OF HYDROGEN-SULFIDE IN AN OPEN-TUBULAR REACTOR, International journal of hydrogen energy, 20(10), 1995, pp. 777-783
Authors:
TENG RL
HARRIS SC
NIX DE
SCHENTAG JJ
FOULDS G
LISTON TE
Citation: Rl. Teng et al., PHARMACOKINETICS AND SAFETY OF TROVAFLOXACIN (CP-99,219), A NEW QUINOLONE ANTIBIOTIC, FOLLOWING ADMINISTRATION OF SINGLE ORAL DOSES TO HEALTHY MALE-VOLUNTEERS, Journal of antimicrobial chemotherapy, 36(2), 1995, pp. 385-394
Citation: V. Meeyoo et al., THE H2S DECOMPOSITION ACTIVITY OF SUPPORTED MOS2 CATALYSTS PREPARED VIA PFHS METHOD, Reaction kinetics and catalysis letters, 56(2), 1995, pp. 231-240
Citation: Mc. Nahata et al., PHARMACOKINETICS OF AZITHROMYCIN IN PEDIATRIC-PATIENTS WITH ACUTE OTITIS-MEDIA, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1875-1877
Citation: Mc. Nahata et al., PHARMACOKINETICS OF AZITHROMYCIN IN PEDIATRIC-PATIENTS WITH ACUTE OTITIS-MEDIA, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 178-178
Authors:
ODAY DM
HEAD WS
FOULDS G
ROBINSON RD
WILLIAMS TE
FERRAINA RA
Citation: Dm. Oday et al., OCULAR PHARMACOKINETICS OF ORALLY-ADMINISTERED AZITHROMYCIN IN RABBITS, Journal of ocular pharmacology, 10(4), 1994, pp. 633-641
Authors:
KUSCHNER RA
HEPPNER DG
ANDERSEN SL
WELLDE BT
HALL T
SCHNEIDER I
BALLOU WR
FOULDS G
SADOFF JC
SCHUSTER B
TAYLOR DN
Citation: Ra. Kuschner et al., AZITHROMYCIN PROPHYLAXIS AGAINST A CHLOROQUINE-RESISTANT STRAIN OF PLASMODIUM-FALCIPARUM, Lancet, 343(8910), 1994, pp. 1396-1397